Table 8.
Follow-up schedule for group 2: patients without local therapy in the retroperitoneum
| Time, years | 1 | 2 | 3 | 4 | 5 | >6 |
| Follow-up schedule (visits), n /year | 4 | 4 | 2 | 2 | 2 | 1 |
| CT of the abdomen (frequency)a, months | 6+12 | 24 | − | − | − | − |
| Ultrasound of the abdomen (frequency), months | (6b) | 18 | 36 | 48 | 60 | − |
| Ultrasound of the testes, n /year | 1 | 1 | 1 | 1 | 1 | 1 |
| Chest X-ray (frequency), months | 6+12 | 18+24 | 36 | 48 | 60 | − |
| Physical examination of blood pressure/BMI/markers, n | 4 | 4 | 2 | 2 | 2 | 1 |
| Extended lab tests including hormones/lipids, n /year | 1 | 1 | 1 | 1 | 1 | 1 |
| Check for late toxicityb, n/year | At least 1 | At least 1 | At least 1 | At least 1 | At least 1 | At least 1 |
Seminoma I + 1× carbo, seminoma IIA/IIB/C, III good + 3× PEB/4 EP, non-seminomatous GCT I high + 2× PEB, non-seminomatous GCT IIA-C, III good +3× PEB. No CT in month 6 for seminoma and non-seminomatous GCT stage I after chemotherapy, but ultrasound of the abdomen. In non-seminomatous GCT with initial supradiaphragmal involvement (stage III) instead of a chest X-ray: chest CT at 6, 12, and 24 months.
a
15% of recurrences in stage I seminoma still occur after 3 years, so that follow-up with CT of the abdomen may have to be adjusted.
b
Intervals must be adapted to the respective therapy.